Amgen Said to Join Health-Care Pack Weighing Medivation Bids

  • U.S. drug company said to discuss potential bid with advisers
  • Sanofi made offer for Medivation; Pfizer, Novartis circling

Amgen Inc. is considering a bid for Medivation Inc., joining a group of suitors circling the cancer therapy company, according to people with knowledge of the matter.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.